🇺🇸 FDA
Patent

US 12012459

OX40-binding polypeptides and uses thereof

granted A61KA61K35/17A61P

Quick answer

US patent 12012459 (OX40-binding polypeptides and uses thereof) held by Inhibrx, Inc. expires Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inhibrx, Inc.
Grant date
Tue Jun 18 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K35/17, A61P, A61P35/00